{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:44:25Z","timestamp":1793400265926,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.diabres.2022.110045","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T14:50:54Z","timestamp":1660747854000},"page":"110045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed\u2122 780G advanced hybrid closed\u2011loop system: A randomized controlled trial"],"prefix":"10.1016","volume":"191","author":[{"given":"Nancy Samir","family":"Elbarbary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Abdel Rahman","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2022.110045_b0005","unstructured":"The Holy Quran. Surah Al-Baqarah 2:183\u2013185."},{"key":"10.1016\/j.diabres.2022.110045_b0010","doi-asserted-by":"crossref","first-page":"109185","DOI":"10.1016\/j.diabres.2021.109185","article-title":"Diabetes and Ramadan: practical guidelines 2021","volume":"185","author":"Hassanein","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"10.1016\/j.diabres.2022.110045_b0015","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2337\/diacare.28.9.2305","article-title":"Recommendations for management of diabetes during Ramadan","volume":"28","author":"Al-Arouj","year":"2005","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.diabres.2022.110045_b0020","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/dc10-0896","article-title":"Recommendations for management of diabetes during Ramadan: update 2010","volume":"33","author":"Al-Arouj","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110045_b0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diabres.2017.03.003","article-title":"Diabetes and Ramadan: practical guidelines","volume":"126","author":"Hassanein","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.diabres.2022.110045_b0030","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2337\/diacare.27.10.2306","article-title":"A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422\/2001 (EPIDIAR) study","volume":"27","author":"Salti","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110045_b0035","doi-asserted-by":"crossref","first-page":"108626","DOI":"10.1016\/j.diabres.2020.108626","article-title":"Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: the DaR Global survey","volume":"172","author":"Hassanein","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.diabres.2022.110045_b0040","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.2337\/dc15-1108","article-title":"Blood glucose fluctuation during Ramadan fasting in adolescents with type 1 diabetes: findings of continuous glucose monitoring","volume":"38","author":"Kaplan","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110045_b0045","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40618-017-0633-y","article-title":"Correlation between pre-Ramadan glycemic control and subsequent glucose fuctuation during fasting in adolescents with type 1 diabetes","volume":"40","author":"Afandi","year":"2017","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.diabres.2022.110045_b0050","doi-asserted-by":"crossref","first-page":"366","DOI":"10.15537\/smj.2017.4.18750","article-title":"Flash glucose monitoring system may benefit children and adolescents with type 1 diabetes during fasting at Ramadan","volume":"38","author":"Al-Agha","year":"2017","journal-title":"Saudi Med J"},{"issue":"1","key":"10.1016\/j.diabres.2022.110045_b0055","doi-asserted-by":"crossref","first-page":"e001248","DOI":"10.1136\/bmjdrc-2020-001248","article-title":"Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA\/EASD consensus","volume":"8","author":"Ibrahim","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"4","key":"10.1016\/j.diabres.2022.110045_b0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5144\/0256-4947.2008.305","article-title":"Insulin pump therapy during Ramadan fasting in type 1 diabetic adolescents","volume":"28","author":"Bin-Abbas","year":"2008","journal-title":"Ann Saudi Med"},{"issue":"6","key":"10.1016\/j.diabres.2022.110045_b0065","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/jdi.13054","article-title":"Safety of Ramadan fasting in young patients with type 1 diabetes: a systematic review and meta-analysis","volume":"10","author":"Loh","year":"2019","journal-title":"J Diabetes Investig"},{"issue":"6","key":"10.1016\/j.diabres.2022.110045_b0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1089\/dia.2016.0418","article-title":"Comparison of insulin pump therapy and multiple daily injections insulin regimen in patients with type 1 diabetes during ramadan fasting","volume":"19","author":"Alamoudi","year":"2017","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"10.1016\/j.diabres.2022.110045_b0075","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/dmrr.2781","article-title":"Effectiveness of the low-glucose suspend feature of insulin pump during fasting during Ramadan in type 1 diabetes mellitus","volume":"32","author":"Elbarbary","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"issue":"S1","key":"10.1016\/j.diabres.2022.110045_b0080","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1089\/dia.2018.2503","article-title":"Insulin pumps","volume":"20","author":"Pickup","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"10.1016\/j.diabres.2022.110045_b0085","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/dia.2019.0105","article-title":"A clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm","volume":"21","author":"Messer","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.diabres.2022.110045_b0090","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00125-021-05391-w","article-title":"New closed-loop insulin systems","volume":"64","author":"Boughton","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.110045_b0095","doi-asserted-by":"crossref","first-page":"802419","DOI":"10.3389\/fendo.2021.802419","article-title":"A comparison of two hybrid closed-loop systems in italian children and adults with type 1 diabetes","volume":"12","author":"Bassi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.diabres.2022.110045_b0100","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/dia.2021.0319","article-title":"Safety and glycemic outcomes during the MiniMed\u2122 advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes","volume":"24","author":"Carlson","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"10.1016\/j.diabres.2022.110045_b0105","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/dia.2021.0037","article-title":"Rapid improvement in time in range after the implementation of an advanced hybrid closed-loop system in adolescents and adults with Type 1 diabetes","volume":"23","author":"Beato-V\u00edbora","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"10.1016\/j.diabres.2022.110045_b0110","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1089\/dia.2019.0400","article-title":"Prospective analysis of the impact of commercialized hybrid closed-loop system on glycemic control, glycemic variability, and patient-related outcomes in children and adults: a focus on superiority over predictive low-glucose suspend technology","volume":"22","author":"Beato-V\u00edbora","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2022.110045_b0115","doi-asserted-by":"crossref","DOI":"10.1111\/pedi.12872","article-title":"Reduced burden of diabetes and improved quality of life: experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes","author":"Musolino","year":"2019","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabres.2022.110045_b0120","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2022.110045_b0125","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020 ;43:S14-S31.","DOI":"10.2337\/dc20-S002"},{"issue":"4","key":"10.1016\/j.diabres.2022.110045_b0130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ecl.2020.07.006","article-title":"New and emerging technologies in type 1 diabetes","volume":"49","author":"Sherwood","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"18","key":"10.1016\/j.diabres.2022.110045_b0135","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","article-title":"iDCL trial research group. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.diabres.2022.110045_b0140","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa2004736","article-title":"iDCL Trial Research Group. A randomized trial of closed-loop control in children with type 1 diabetes","volume":"383","author":"Breton","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2022.110045_b0145","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2022.110045_b0150","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2213-8587(21)00054-1","article-title":"Post-exercise recovery for the endurance athlete with type 1 diabetes: a consensus statement","volume":"9","author":"Scott","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2022.110045_b0155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/pedi.12920","article-title":"ISPAD clinical practice consensus guidelines: fasting during ramadan by young people with diabetes","volume":"21","author":"Deeb","year":"2020","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2022.110045_b0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/18715303113139990010","article-title":"Effect of fasting ramadan in diabetes control status - application of extensive diabetes education, serum creatinine with HbA1c statistical ANOVA and regression models to prevent hypoglycemia","volume":"7","author":"Aziz","year":"2013","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"10.1016\/j.diabres.2022.110045_b0165","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.diabres.2017.10.010","article-title":"Comparison of continuous glucose monitoring in adolescents with type 1 diabetes: Ramadan versus non-Ramadan","volume":"134","author":"Kaplan","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"issue":"S2","key":"10.1016\/j.diabres.2022.110045_b0170","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1089\/dia.2018.0091","article-title":"The hybrid closed-loop system: evolution and practical applications","volume":"20","author":"Weaver","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.diabres.2022.110045_b0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00592-019-01414-6","article-title":"Glucose control during Ramadan fasting in a teenager with type 1 diabetes on MiniMed 670G hybrid closed-loop system","volume":"57","author":"Petrovski","year":"2020","journal-title":"Acta Diabetol"},{"issue":"8","key":"10.1016\/j.diabres.2022.110045_b0180","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/dom.14439","article-title":"A real-world study of user characteristics, safety and efficacy of opensource closed-loop systems and Medtronic 670G","volume":"23","author":"Jeyaventhan","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.diabres.2022.110045_b0185","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/dc20-2250","article-title":"Improved glycemic outcomes with Medtronic MiniMed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes","volume":"44","author":"Collyns","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110045_b0190","doi-asserted-by":"crossref","unstructured":"Bekiari\u2008E, Kitsios\u2008K, Thabit\u2008H, Tauschmann M, Athanasiadou E, Karagiannis T, et al. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ\u20082018;361:k1310.","DOI":"10.1136\/bmj.k1310"},{"key":"10.1016\/j.diabres.2022.110045_b0195","doi-asserted-by":"crossref","unstructured":"de Bock M, Dart J, Hancock M, Smith G, Davis EA, Jones TW. Performance of Medtronic hybrid closed-loop iterations: results from a randomized trial in adolescents with type 1 diabetes. Diabetes Technol Ther 2018;20:693\u2013697.","DOI":"10.1089\/dia.2018.0161"},{"issue":"4","key":"10.1016\/j.diabres.2022.110045_b0200","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1089\/dia.2020.0448","article-title":"Feasibility study of a hybrid closed-loop system with automated insulin correction boluses","volume":"23","author":"Nimri","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.diabres.2022.110045_b0205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/dia.2018.0279","article-title":"Glucose control using a standard versus an enhanced hybrid closed loop system: a randomized crossover study","volume":"21","author":"Paldus","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"18","key":"10.1016\/j.diabres.2022.110045_b0210","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","article-title":"Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.diabres.2022.110045_b0215","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.2337\/dc21-0172","article-title":"Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes","volume":"44","author":"Brown","year":"2021","journal-title":"Diabetes Care"},{"issue":"10155","key":"10.1016\/j.diabres.2022.110045_b0220","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(18)31947-0","article-title":"Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial","volume":"392","author":"Tauschmann","year":"2018","journal-title":"Lancet"},{"issue":"10270","key":"10.1016\/j.diabres.2022.110045_b0225","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(20)32514-9","article-title":"A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial","volume":"397","author":"Bergenstal","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.diabres.2022.110045_b0230","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12902-022-00996-7","article-title":"Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)","volume":"22","author":"Petrovski","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"11","key":"10.1016\/j.diabres.2022.110045_b0235","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s13300-020-00886-y","article-title":"Ramadan and diabetes: a narrative review and practice update","volume":"11","author":"Ahmed","year":"2020","journal-title":"Diabetes Ther"},{"issue":"4","key":"10.1016\/j.diabres.2022.110045_b0240","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/jdi.13720","article-title":"Use of automated insulin delivery systems in people with type 1 diabetes fasting during Ramadan: an observational study","volume":"13","author":"Aldibbiat","year":"2022","journal-title":"J Diabetes Investig"},{"issue":"2","key":"10.1016\/j.diabres.2022.110045_b0245","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/pedi.12962","article-title":"Six months of hybrid closed loop in the real-world: an evaluation of children and young adults using the 670G system","volume":"21","author":"Berget","year":"2020","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"10.1016\/j.diabres.2022.110045_b0250","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00592-019-01472-w","article-title":"10-Day structured initiation protocol from multiple daily injection to hybrid closed-loop system in children and adolescents with type 1 diabetes","volume":"57","author":"Petrovski","year":"2020","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2022.110045_b0255","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.diabres.2019.02.019","article-title":"Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with type 1 diabetes mellitus who fast during Ramadan: a systematic review and meta-analysis","volume":"151","author":"Gad","year":"2019","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:23:07Z","timestamp":1759173787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722008592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":51,"alternative-id":["S0168822722008592"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110045","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed\u2122 780G advanced hybrid closed\u2011loop system: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110045"}}